AGE - Contribution to the revision of the clinical trials directive
11 May 2011
AGE contributed to the consultation open by the European Commission on the revision of the clinical trials directive. Considering the recent development regarding geriatric medicines, particular the decision made by the European Medicine Agency (EMA) in February 2011 to launch a geriatric medicines strategy, AGE Platform Europe considered this revision of the directive has an opportunity to support this new strategy and decided to focus its contribution on the need to improve participation of older people in clinical trials of medicines commonly used for geriatric patients.
For more information, please click here